18F-PSMA-1007 is a fluorine-18 labeled PSMA-targeting ligand combining a peptidomimetic binding motif with a radiolabeled prosthetic group. The structure is optimized for receptor affinity and metal-free radionuclide attachment. Researchers investigate its kinetics, binding constants, and metabolic stability in model systems. Applications include tracer-design studies, PSMA-epitope mapping, and radioligand-structure optimization.
CAT No: ta-586
Synonyms/Alias:18F-PSMA 1007; (2~{S})-2-[[(2~{S})-6-[[(2~{S})-2-[[4-[[[(2~{S})-2-[[(2~{S})-2-[(6-fluoranylpyridin-3-yl)carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]methyl]phenyl]carbonylamino]-3-naphthalen-2-yl-propanoyl]amino]-1-oxidanyl-1-oxidanylidene-hexan-2-yl]carbamoylamino]pentanedioic acid; 2093321-18-5; SCHEMBL20180889; F-PSMA 1007; PSMA-1007?; AT43725; 9OT
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More